Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Claiborne Cary J Create: Alert

All | News | Filings
Date FiledTypeDescription
05/25/2023 4 Claiborne Cary J (CEO) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 420,000 shares @ $0
Granted 300,000 options to buy @ $0.3025, valued at $90.8k
09/20/2022 4 Claiborne Cary J (CEO) has filed a Form 4 on ADIAL PHARMACEUTICALS, INC.
Txns: Granted 25,000 shares @ $0.4294, valued at $10.7k
Granted 75,000 shares @ $0.4202, valued at $31.5k
08/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/28/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
02/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/03/2021 3 Claiborne Cary J (Director) has filed a Form 3 on ADIAL PHARMACEUTICALS, INC.
12/17/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
09/15/2014 4 Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.
Txns: Granted 22,027 options to buy @ $6.75, valued at $148.7k
Granted 25,000 options to buy @ $6.75, valued at $168.8k
07/10/2014 4 Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.
Txns: Granted 267 shares @ $6.56, valued at $1.8k
07/10/2014 4 Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.
Txns: Granted 220 shares @ $6.79, valued at $1.5k
02/28/2014 4 Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.
Txns: Sold 2,390 shares @ $9, valued at $21.5k
Sold 110 shares @ $9.06, valued at $996.6
Exercised 2,500 options to buy @ $4.07, valued at $10.2k
01/09/2014 4 Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.
Txns: Sold 2,500 shares @ $9, valued at $22.5k
Exercised 2,400 options to buy @ $4.41, valued at $10.6k
Exercised 100 options to buy @ $4.07, valued at $407
01/06/2014 4 Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.
Txns: Granted 196 shares @ $8.93, valued at $1.8k
11/26/2013 4 Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.
Txns: Exercised (in-or-at-the-money) 3,511 shares @ $7.46, valued at $26.2k
Exercised (in-or-at-the-money) 12,989 shares @ $7.64, valued at $99.2k
Exercised (in-or-at-the-money) 3,511 options to buy @ $4.07, valued at $14.3k
Exercised (in-or-at-the-money) 12,940 options to buy @ $4.07, valued at $52.7k
Exercised (in-or-at-the-money) 49 options to buy @ $4.07, valued at $199.4
10/01/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
05/29/2013 4 Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.
Txns: Exercised (in-or-at-the-money) 10,300 shares @ $9.0034, valued at $92.7k
Exercised (in-or-at-the-money) 8,300 options to buy @ $4.07, valued at $33.8k
Exercised (in-or-at-the-money) 2,000 options to buy @ $4.41, valued at $8.8k
01/04/2013 4 Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.
Txns: Granted 376 shares @ $4.655, valued at $1.8k
10/02/2012 4 Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.
Txns: Granted 313 shares @ $4.7785, valued at $1.5k
07/20/2012 4 Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.
Txns: Granted 263 shares @ $6.6785, valued at $1.8k
04/06/2012 4 Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.
Txns: Granted 211 shares @ $7.0775, valued at $1.5k
10/27/2011 4 Claiborne Cary J (CFO) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.
Txns: Granted 51,760 options to buy @ $4.07, valued at $210.7k
Granted 77,640 options to buy @ $4.07, valued at $316k
10/27/2011 3 Claiborne Cary J (CFO) has filed a Form 3 on Sucampo Pharmaceuticals, Inc.
02/14/2011 5 Form 5 - Annual statement of changes in beneficial ownership of securities
12/29/2009 4 Form 4 - Statement of changes in beneficial ownership of securities
12/22/2009 4 Claiborne Cary J (CEO, CFO and President) has filed a Form 4 on New Generation Biofuels Holdings, Inc
Txns: Bought 1,500 shares @ $0.71, valued at $1.1k
Bought 1,019 shares @ $0.72, valued at $733.7
Bought 7,481 shares @ $0.7, valued at $5.2k
Bought 4,600 shares @ $0.7, valued at $3.2k
Bought 5,400 shares @ $0.69, valued at $3.7k
12/21/2009 4 Claiborne Cary J (CEO, CFO and President) has filed a Form 4 on New Generation Biofuels Holdings, Inc
Txns: Granted 29,070 shares @ $0
08/28/2009 4 Claiborne Cary J (CEO, CFO and President) has filed a Form 4 on New Generation Biofuels Holdings, Inc
07/01/2009 4/A Claiborne Cary J (CEO, CFO and President) has filed a Form 4 on New Generation Biofuels Holdings, Inc
07/01/2009 4/A Claiborne Cary J (President, CEO & CFO) has filed a Form 4 on New Generation Biofuels Holdings, Inc
06/11/2009 4 Claiborne Cary J (CEO, CFO and President) has filed a Form 4 on New Generation Biofuels Holdings, Inc
05/29/2009 4 Claiborne Cary J (President, CEO & CFO) has filed a Form 4 on New Generation Biofuels Holdings, Inc
01/16/2009 4 Claiborne Cary J (CFO) has filed a Form 4 on New Generation Biofuels Holdings, Inc

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy